182 related articles for article (PubMed ID: 23122937)
1. Triazole pyrimidine nucleosides as inhibitors of Ribonuclease A. Synthesis, biochemical, and structural evaluation.
Parmenopoulou V; Chatzileontiadou DS; Manta S; Bougiatioti S; Maragozidis P; Gkaragkouni DN; Kaffesaki E; Kantsadi AL; Skamnaki VT; Zographos SE; Zounpoulakis P; Balatsos NA; Komiotis D; Leonidas DD
Bioorg Med Chem; 2012 Dec; 20(24):7184-93. PubMed ID: 23122937
[TBL] [Abstract][Full Text] [Related]
2. Morpholino, piperidino, and pyrrolidino derivatives of pyrimidine nucleosides as inhibitors of ribonuclease A: synthesis, biochemical, and crystallographic evaluation.
Samanta A; Leonidas DD; Dasgupta S; Pathak T; Zographos SE; Oikonomakos NG
J Med Chem; 2009 Feb; 52(4):932-42. PubMed ID: 19173562
[TBL] [Abstract][Full Text] [Related]
3. 5'-Modified pyrimidine nucleosides as inhibitors of ribonuclease A.
Samanta A; Dasgupta S; Pathak T
Bioorg Med Chem; 2011 Apr; 19(7):2478-84. PubMed ID: 21420869
[TBL] [Abstract][Full Text] [Related]
4. Triazole double-headed ribonucleosides as inhibitors of eosinophil derived neurotoxin.
Chatzileontiadou DS; Parmenopoulou V; Manta S; Kantsadi AL; Kylindri P; Griniezaki M; Kontopoulou F; Telopoulou A; Prokova H; Panagopoulos D; Boix E; Balatsos NA; Komiotis D; Leonidas DD
Bioorg Chem; 2015 Dec; 63():152-65. PubMed ID: 26551065
[TBL] [Abstract][Full Text] [Related]
5. Toward rational design of ribonuclease inhibitors: high-resolution crystal structure of a ribonuclease A complex with a potent 3',5'-pyrophosphate-linked dinucleotide inhibitor.
Leonidas DD; Shapiro R; Irons LI; Russo N; Acharya KR
Biochemistry; 1999 Aug; 38(32):10287-97. PubMed ID: 10441122
[TBL] [Abstract][Full Text] [Related]
6. The binding of IMP to ribonuclease A.
Hatzopoulos GN; Leonidas DD; Kardakaris R; Kobe J; Oikonomakos NG
FEBS J; 2005 Aug; 272(15):3988-4001. PubMed ID: 16045769
[TBL] [Abstract][Full Text] [Related]
7. High-resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhibitors. Implications for structure-based design of ribonucleolytic inhibitors.
Leonidas DD; Chavali GB; Oikonomakos NG; Chrysina ED; Kosmopoulou MN; Vlassi M; Frankling C; Acharya KR
Protein Sci; 2003 Nov; 12(11):2559-74. PubMed ID: 14573867
[TBL] [Abstract][Full Text] [Related]
8. Coulombic effects of remote subsites on the active site of ribonuclease A.
Fisher BM; Schultz LW; Raines RT
Biochemistry; 1998 Dec; 37(50):17386-401. PubMed ID: 9860854
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of ribonuclease A complexes with 5'-diphosphoadenosine 3'-phosphate and 5'-diphosphoadenosine 2'-phosphate at 1.7 A resolution.
Leonidas DD; Shapiro R; Irons LI; Russo N; Acharya KR
Biochemistry; 1997 May; 36(18):5578-88. PubMed ID: 9154942
[TBL] [Abstract][Full Text] [Related]
10. Nucleoside-amino acid conjugates: An alternative route to the design of ribonuclease A inhibitors.
Debnath J; Dasgupta S; Pathak T
Bioorg Med Chem; 2009 Jul; 17(14):4921-7. PubMed ID: 19540766
[TBL] [Abstract][Full Text] [Related]
11. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
[TBL] [Abstract][Full Text] [Related]
12. The crystal structure of ribonuclease A in complex with thymidine-3'-monophosphate provides further insight into ligand binding.
Doucet N; Jayasundera TB; Simonović M; Loria JP
Proteins; 2010 Aug; 78(11):2459-68. PubMed ID: 20602460
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases.
Pous J; Canals A; Terzyan SS; Guasch A; Benito A; Ribó M; Vilanova M; Coll M
J Mol Biol; 2000 Oct; 303(1):49-60. PubMed ID: 11021969
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor design for ribonuclease A: the binding of two 5'-phosphate uridine analogues.
Tsirkone VG; Dossi K; Drakou C; Zographos SE; Kontou M; Leonidas DD
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Jul; 65(Pt 7):671-7. PubMed ID: 19574636
[TBL] [Abstract][Full Text] [Related]
15. Coulombic forces in protein-RNA interactions: binding and cleavage by ribonuclease A and variants at Lys7, Arg10, and Lys66.
Fisher BM; Ha JH; Raines RT
Biochemistry; 1998 Sep; 37(35):12121-32. PubMed ID: 9724524
[TBL] [Abstract][Full Text] [Related]
16. Comparative inhibitory activity of 3'- and 5'-functionalized nucleosides on ribonuclease A.
Debnath J; Dasgupta S; Pathak T
Bioorg Med Chem; 2010 Dec; 18(23):8257-63. PubMed ID: 21041096
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence assay for the binding of ribonuclease A to the ribonuclease inhibitor protein.
Abel RL; Haigis MC; Park C; Raines RT
Anal Biochem; 2002 Jul; 306(1):100-7. PubMed ID: 12069420
[TBL] [Abstract][Full Text] [Related]
18. 1-(3-Deoxy-3-fluoro-beta-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modelling studies.
Tsirkone VG; Tsoukala E; Lamprakis C; Manta S; Hayes JM; Skamnaki VT; Drakou C; Zographos SE; Komiotis D; Leonidas DD
Bioorg Med Chem; 2010 May; 18(10):3413-25. PubMed ID: 20430629
[TBL] [Abstract][Full Text] [Related]
19. The binding of 3'-N-piperidine-4-carboxyl-3'-deoxy-ara-uridine to ribonuclease A in the crystal.
Leonidas DD; Maiti TK; Samanta A; Dasgupta S; Pathak T; Zographos SE; Oikonomakos NG
Bioorg Med Chem; 2006 Sep; 14(17):6055-64. PubMed ID: 16730994
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A.
Kobe B; Deisenhofer J
J Mol Biol; 1996 Dec; 264(5):1028-43. PubMed ID: 9000628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
